Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Springer logoLink to Springer
. 2017 Oct 23;144(1):187–188. doi: 10.1007/s00432-017-2532-1

Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase

Juan Luis Steegmann 1,, Dolors Colomer 2, Maria-Teresa Gómez-Casares 3, Valentín García-Gutiérrez 4, Guillermo Ortí 5, Angel Ramírez-Payer 6, Eduardo Olavarria 7, Ferrán Vall-llovera 8, Pilar Giraldo 9, Eulogio Conde 10, Rolando Vallansot 11, Jose Luis López-Lorenzo 12, Luis Palomera 13, Alberto Álvarez-Larrán 14, Venancio Conesa 15, Guiomar Bautista 16, Laura Casas 17, Frank Giles 18, Andreas Hochhaus 19, Luis Felipe Casado-Montero 20
PMCID: PMC5756548  PMID: 29063181

Correction to: J Cancer Res Clin Oncol (2017) 143:2059–2066 DOI 10.1007/s00432-017-2445-z

The article “An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase”, written by Juan Luis Steegmann, Dolors Colomer, Maria-Teresa Gómez-Casares, Valentín García-Gutiérrez, Guillermo Ortí, Angel Ramírez-Payer, Eduardo Olavarria, Ferrán Vall-llovera, Pilar Giraldo, Eulogio Conde, Rolando Vallansot, Jose Luis López-Lorenzo, Luis Palomera, Alberto Álvarez-Larrán, Venancio Conesa, Guiomar Bautista, Laura Casas, Frank Giles, Andreas Hochhaus, Luis Felipe Casado-Montero, was originally published Online First without open access.

After publication in volume 143, issue 10, pages 2059–2066 the authors decided to opt for Open Choice and to make the article an open access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2017 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Footnotes

The online version of the original article can be found under doi:10.1007/s00432-017-2445-z.


Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES